Gilead Falls as Drug Has Only Small Benefit in Large Trial

(Bloomberg) -- Gilead Sciences Inc.’s drug remdesivir showed only a limited benefit in a large trial of more moderate patients with Covid-19, a result that may shift perceptions of the therapy alre...